ADVANSIX INC. DL-,01

In Q2 AdvanSix reported $421 million in sales while adjusted EBITDA fell to $32 million and adjusted EPS to $0.19. A $72 million year-over-year rise in raw material costs was fully offset by pricing (18% favorable pricing vs 15% volume decline), but fertilizer and chemical volumes were weaker than expected as farmers cut back and sulfur hit record prices. Management expects stronger cash flow in H2 2026, plans to grow ammonia sales volume 30% in 2026 and is pursuing a USDA grant and 45Q tax credits to support capacity and carbon capture economics. » More on finance.yahoo.com

AdvanSix reported significant sequential earnings improvement after raw material costs swung from a $10 million Q1 headwind to a $39 million Q2 tailwind and management offset $72 million of year-over-year raw material pressure through disciplined pricing. The company saw softer-than-expected plant nutrient volumes due to weak crop economics but maintained near‑record domestic granular ammonium sulfate volume for the fertilizer year. Operationally, the ammonia plant turnaround aligned with pipeline inspections and ran at mid-70% utilization, while integrated asset optimization increased ammonia sales availability by 30% year‑over‑year. Management expects materially stronger EBITDA and cash flow in H2 2026, forecasts a ~$200/long ton decline in sulfur into 2027 as a tailwind, targets ~$10 million in fixed‑cost savings exiting 2026, and plans a DEF project FID in H1 2027; $18 million in Section 45Q credits is accrued with payment expected in H2 2026. » More on finance.yahoo.com

AdvanSix reported Q1 sales of $404 million, up 7% year over year, driven by higher chemical intermediates volumes and stronger plant nutrients pricing. Adjusted EBITDA fell to $5 million, hurt by record sulfur and higher natural gas costs, winter storm disruptions and the absence of prior-year insurance proceeds. Management expects meaningful sequential improvement in Q2 as raw material cost recovery and seasonal fertilizer demand help margins, and reaffirmed full-year capex of $75–95 million and a target leverage near the low end of its range. The company is evaluating a DEF expansion at its Hopewell site with a potential final investment decision in H1 2027 and commercial start-up targeted for 2029. » More on finance.yahoo.com